Agilon Health shares fall 24.52% premarket after CEO Steven Sell stepped down and Q2 earnings miss expectations.

Agilon Health, Inc. dropped 24.52% in premarket trading, following the announcement that President, CEO, and Board Director Steven Sell stepped down from his positions. The company also reported a bigger-than-expected Q2 net loss and withdrew its full-year 2025 financial guidance. Additionally, Agilon is being investigated for potential securities fraud violations, which has further contributed to the stock's decline.